Analysis of 510(k) Summary: K232613 CT Cardiomegaly

December 29, 2025

Yujan Shrestha

SHARE ON

ArticleAI/ML

What FDA Reviewers Will Ask About Your Bland-Altman Sample Size

A step-by-step guide to using Monte Carlo simulation for estimating the sample size needed to pass Bland-Altman Limits of Agreement acceptance criteria with bootstrap confidence...

Yujan Shrestha & Nishant Dahal

Feb 18, 2026

Let's Talk

Every great partnership starts with a conversation. Fill out the form below for a discovery call, and an Innolitics team member will contact you soon.

I learned more from an hour-long Innolitics sales call than an entire paid engagement from other consultants.

Richard Clark

Executive in Residence at Washington University

Software Development

FDA Regulatory Consulting

FDA Cybersecurity

Concept to Cleared Device

FDA Strategy & Pre-Sub in 4 Weeks

Breakthrough Designation in 2 Weeks

AI/ML Submission in 3 Months

FDA Hold Letter Rescue

FDA-Ready QMS in 2 Months

Analysis of 510(k) Summary: K232613 CT Cardiomegaly

Related Articles

What FDA Reviewers Will Ask About Your Bland-Altman Sample Size

Let's Talk